Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician survey

Clinical Therapeutics, 2016 02; 5(2): 209-220

Our aim was to compare the efficacy and tolerability of daclatasvir plus sofosbuvir (DCV+SOF) versus SOF plus ribavirin (SOF+R) in patients coinfected with HIV and hepatitis C virus (HCV).

View abstract

Authors

Lin PL, Hao Y, Xie J, Li N, Zhong Y, Zhou Z, Signorovitch JE, Wu EQ.